CSS
TBRA

Cubist Systematic Strategies’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Cubist Systematic Strategies’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-216
Closed -$2K – 2011
2016
Q1 		$2K Sell
216
-1,278
-86% -$9.64K ﹤0.01% 1573
2015
Q4 		$15K Buy
1,494
+1,316
+739% +$13.7K ﹤0.01% 1692
2015
Q3 		$2K Buy
+178
New +$2.5K ﹤0.01% 1832

Other funds holding TBRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Cubist Systematic Strategies's TBRA Position: Q2 2016 in Review

Cubist Systematic Strategies sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q2 2016, closing a stake of 216 shares — an estimated $2K sold.

Cubist Systematic Strategies first reported a position in TBRA in Q3 2015 and held it in 3 quarters. The position peaked at $15K in Q4 2015. 45 funds tracked by Wall St. Rank hold TBRA as of Q2 2016.

  • Cubist Systematic Strategies reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Cubist Systematic Strategies sold 216 Tobira Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $2K.
  • Cubist Systematic Strategies first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2015 and held it in 3 quarters.
  • Cubist Systematic Strategies's Tobira Therapeutics, Inc. Common Stock position peaked at $15K in Q4 2015.
  • 45 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Cubist Systematic Strategies's 13F filing for Q2 2016, filed 15 Aug 2016.